CCTA

CCTA seeks to raise public awareness about the societal benefits of #clinicaltrials with the goal of encouraging more patients to consider participating.

[CCTA @CCTAwareness]

Patients are eager for new and better treatments, yet more than one-third of clinical trials do not meet their enrollment goals.

Read more on how the federal government can improve clinical trials awareness: https://t.co/XFz6zBS9Ak

[CCTA @CCTAwareness]

#DYK? 90% of medications administered to newborns are not approved by the @US_FDA for use in the newborn population.

Learn more: https://t.co/Q9MDdJPR6o

[CCTA @CCTAwareness]

Learn about overcoming financial barriers to clinical trials enrollment in this CCTA paper ▶️ https://t.co/sALpbhIA4m

[CCTA @CCTAwareness]

Why Alzheimer's and Parkinson's patients need clinical trials awareness? Learn here: https://t.co/bCPxvkpmdb

[CCTA @CCTAwareness]

DYK? Just 1 out of 3 cardiovascular trial participants are women. Cures begin with clinical trials awareness.

[CCTA @CCTAwareness]

Only 1 out of 10 people with Parkinson's disease participate in a clinical trial. Cures begin with clinical trials awareness.

[CCTA @CCTAwareness]

DYK? 40% of cancer trials don't meet minimum patient enrollment. Cures begin with clinical trials awareness.

[CCTA @CCTAwareness]

Aging affects how people absorb, metabolize and excrete drugs. Yet clinical trials focus on participants aged 18-64.

Seniors shouldn't miss out on clinical trials: https://t.co/tBiVwFGbt1

[CCTA @CCTAwareness]

DYK? 90% of medications administered to newborns are not approved by the Food and Drug Administration for use in the newborn population.

Learn more: https://t.co/Q9MDdJPR6o

[CCTA @CCTAwareness]

Clinical trials offer treatment options for patients. But trial participation can present unexpected costs for these patients.

Learn more: https://t.co/oW5z8msTuw

[CCTA @CCTAwareness]

Public awareness is the essential factor driving increased engagement in clinical trials, ultimately fostering innovation and addressing patients' health care needs.

Learn more: https://t.co/p23vsyrxaw

[CCTA @CCTAwareness]

Clinical trials are an important step in the development of breakthrough treatments.

But there’s a problem: Not enough people join clinical trials.

Learn more: https://t.co/Th4ThxZXBy

[CCTA @CCTAwareness]

DYK? Patients 65 and older tend to take more medication than other age groups, yet clinical trials focus on participants aged 18-64.

Learn more ▶️ https://t.co/tBiVwFGbt1

[CCTA @CCTAwareness]

Clinical trials can be costly, but there are solutions to help manage the financial burden.

Learn more ▶️ https://t.co/VlnlSFH1oL

[CCTA @CCTAwareness]

Aging affects how people absorb, metabolize and excrete drugs, yet clinical trials only focus on participants aged 18-64.

Learn more ▶️ https://t.co/tBiVwFGbt1

[CCTA @CCTAwareness]

DYK? 49% of Americans think low enrollment reflects lack of awareness.

Learn more ▶️ https://t.co/XkOltBqbvp

[CCTA @CCTAwareness]

About one-third of clinical trials aimed at Parkinson's disease fail to start due to a shortage of participants. This insufficient enrollment can lead to a loss of potential innovative treatments for the disease.

Learn more ▶️ https://t.co/VJ8KzFELtJ

[CCTA @CCTAwareness]

DYK? About 4 million babies are born each year in the United States, yet 90% of the medications they take have never been tested for children.

Learn more why clinical trials need newborns ▶️ https://t.co/5kQB13CkMw

[CCTA @CCTAwareness]

Clinical trials can have associated costs including parking, travel, child care or lost work income, which can be a serious deterrent to trial participation.

Learn more ▶️ https://t.co/sALpbhIA4m

[CCTA @CCTAwareness]

Clinical trials can have hidden costs for patients. Learn about them from David Charles, MD, in this episode of AfPA's Patient Access Podcast: https://t.co/y5suAiiurJ